| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.31 | 5e-09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.32 | 2e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 4e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 5e-07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.27 | 1e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.22 | 9e-06 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |